This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPED2K1BI_M.jpg
Biogen sees FY 2023 EPS of $15.00-$16.00 versus the analyst consensus of $15.87.
Biogen’s stock price closed at $289.08. It is down -4.56% in the last 3 months and up 34.74% in the last 12 months.
Biogen saw 11 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See Biogen’s stock price’s past reactions to earnings here.
According to InvestingPro, Biogen’s Financial Health score is “great performance“.
Check out Biogen’s recent earnings performance, and Biogen’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
